“Gepotidacin is a novel oral antibacterial treatment with the potential ... the bacteria that cause gonorrhea, rendering many previously used first-line antibiotics ineffective.

Recommended regimens for gonorrhea during pregnancy ... It is also recommended by the WHO as first-line treatment for chlamydia during pregnancy. – Pregnant women with early-stage syphilis ...

Patients treated with trastuzumab deruxtecan + pertuzumab had a statistically significant and clinically meaningful improvement in PFS compared with standard of care. Topline results were ...

That measure was made in comparison to a triple-drug combination currently used as a first-line treatment for this type of cancer. These results are important because many patients with metastatic ...

A Phase 3 trial shows oral gepotidacin is as effective as standard dual therapy for uncomplicated urogenital gonorrhoea. Read ...

AstraZeneca and Daiichi Sankyo are aiming to establish their star antibody-drug conjugate (ADC) Enhertu as a first-line treatment in HER2-positive breast cancer after recording “highly ...

Before the Trodelvy readout, a combination of Pfizer and Astellas’ Nectin-4 ADC Padcev and Keytruda won a full FDA approval in late 2023 as a first-line treatment for advanced bladder cancer.

AZ and Daiichi Sankyo said they intend to move ahead quickly with submissions for first-line use on the strength ... postponing the time until additional treatment may be needed," commented ...

drug to market as a first-line treatment for breast cancer after camizestrant hit the mark in a phase 3 trial. Top-line data from the SERENA-6 trial showed that camizestrant reduced the risk of ...

Although the benefit of first- and second-line treatment over best supportive care alone has been firmly established, the role of further-line treatment remains controversial. This article ...

This comes as a significant development since there are currently no approved treatment options for GAD ... and SNRIs like Effexor are recommended as first-line drug therapies for GAD in other ...

“This is a significant milestone for patients and sets the foundation for ENHERTU in combination with pertuzumab as an important treatment option in the first-line HER2 positive setting.